JP Stock MarketDetailed Quotes

4559 Zeria Pharmaceutical

Watchlist
  • 2152
  • +13+0.61%
20min DelayMarket Closed Jul 19 15:00 JST
114.31BMarket Cap12.27P/E (Static)

Zeria Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zeria Pharmaceutical Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 9, 2024

Revenue(YoY)

17.81B

+6.92%
EPS(YoY)

-15.70

-421.86%
Analyst Rating

Strong Buy

Jul 10, 2024

Zeria Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 9, 20242024/Q417.806B / 17.780B--
Feb 1, 20242024/Q321.241B / 19.470B--
Nov 1, 20232024/Q218.374B / 18.295B--
Aug 3, 20232024/Q118.304B / 17.190B--
May 11, 20232023/Q416.654B / 15.770B--
DatePeriodRevenue/EstimateEarnings Call
May 9, 20242024/Q417.806B / 17.780B--
Feb 1, 20242024/Q321.241B / 19.470B--
Nov 1, 20232024/Q218.374B / 18.295B--
Aug 3, 20232024/Q118.304B / 17.190B--
May 11, 20232023/Q416.654B / 15.770B--

Unlock Free Earnings Estimates

Zeria Pharmaceutical Earnings Reports

  • Zeria Pharmaceutical: Extraordinary Report

    Jul 2 21:44 ET

  • Zeria Pharmaceutical: Confirmation letter

    Jun 27 01:11 ET

  • Zeria Pharmaceutical: Securities Report - 70th period (April 1, 2023 - March 31, 2024)

    Jun 27 01:07 ET

  • Zeria Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

    May 9 03:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 10, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg